IRIS
DALLABONA, Cristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.966
AS - Asia 4.288
EU - Europa 2.935
SA - Sud America 543
AF - Africa 185
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 8
Totale 12.933
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.848
SG - Singapore 1.479
CN - Cina 1.093
IT - Italia 983
VN - Vietnam 659
SE - Svezia 440
IE - Irlanda 423
BR - Brasile 414
HK - Hong Kong 345
BD - Bangladesh 304
FI - Finlandia 225
FR - Francia 194
DE - Germania 168
ZA - Sudafrica 127
NL - Olanda 119
GB - Regno Unito 111
IN - India 73
RU - Federazione Russa 71
CA - Canada 65
TR - Turchia 64
UA - Ucraina 57
AR - Argentina 52
BE - Belgio 30
KR - Corea 29
IQ - Iraq 28
JP - Giappone 28
MX - Messico 28
AT - Austria 26
PK - Pakistan 24
PL - Polonia 24
ES - Italia 22
ID - Indonesia 22
EC - Ecuador 19
PH - Filippine 18
UZ - Uzbekistan 16
VE - Venezuela 14
CO - Colombia 13
MA - Marocco 12
SA - Arabia Saudita 12
LT - Lituania 11
CI - Costa d'Avorio 10
PE - Perù 10
TW - Taiwan 10
IL - Israele 9
IR - Iran 9
UY - Uruguay 9
AZ - Azerbaigian 8
EG - Egitto 8
KE - Kenya 8
TH - Thailandia 8
AE - Emirati Arabi Uniti 7
AU - Australia 7
CL - Cile 7
CZ - Repubblica Ceca 6
DZ - Algeria 6
EU - Europa 6
JO - Giordania 5
LB - Libano 5
NI - Nicaragua 5
TN - Tunisia 5
JM - Giamaica 4
MY - Malesia 4
PT - Portogallo 4
PY - Paraguay 4
AL - Albania 3
BH - Bahrain 3
DK - Danimarca 3
GE - Georgia 3
LK - Sri Lanka 3
OM - Oman 3
QA - Qatar 3
RO - Romania 3
CH - Svizzera 2
CR - Costa Rica 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
HN - Honduras 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LY - Libia 2
MD - Moldavia 2
NP - Nepal 2
PA - Panama 2
PR - Porto Rico 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
ET - Etiopia 1
GR - Grecia 1
HU - Ungheria 1
KH - Cambogia 1
LU - Lussemburgo 1
Totale 12.920
Salva come PNG Salva come JPEG
Città #
Singapore 754
Ashburn 569
San Jose 514
Dallas 419
Dublin 410
Santa Clara 404
Chandler 367
Hong Kong 324
Beijing 283
Parma 219
Ho Chi Minh City 204
Boardman 176
Ann Arbor 170
Los Angeles 156
New York 156
Dearborn 140
Hanoi 132
Johannesburg 111
Shanghai 88
Lauterbourg 87
Jacksonville 78
Nanjing 77
Hefei 75
Princeton 68
Bologna 54
Buffalo 53
Izmir 53
Milan 50
Moscow 44
Wilmington 44
Munich 41
Columbus 39
Helsinki 36
São Paulo 34
Jinan 31
Da Nang 30
Des Moines 30
Brussels 29
Nanchang 28
Shenyang 28
Rome 27
Council Bluffs 25
Nuremberg 25
San Mateo 25
Woodbridge 25
Marseille 24
Haiphong 23
Tokyo 23
Atlanta 22
Toronto 22
Kunming 21
Biên Hòa 20
Houston 20
Changsha 19
Chicago 19
Seoul 19
Guangzhou 18
London 18
The Dalles 18
Warsaw 18
Hebei 17
Reggio Emilia 17
Seattle 17
Turku 17
Belo Horizonte 16
Vienna 16
Hangzhou 15
Montreal 15
Tashkent 15
Tianjin 15
Brooklyn 14
Catania 14
Colchester 14
Falls Church 14
Zhengzhou 14
Frankfurt am Main 13
Phoenix 13
Redmond 13
Fontanellato 12
Hải Dương 12
Jakarta 12
Orem 12
Piacenza 12
Rio de Janeiro 12
Bari 11
Denver 11
Mexico City 11
Modena 11
Abidjan 10
Baghdad 10
Bengaluru 10
Chennai 10
Stockholm 10
Turin 10
Bremen 9
Can Tho 9
Naples 9
Ninh Bình 9
Pistoia 9
Baku 8
Totale 7.534
Salva come PNG Salva come JPEG
Nome #
In Vivo Treatment with a Standardized Green Tea Extract Restores Cardiomyocyte Contractility in Diabetic Rats by Improving Mitochondrial Function through SIRT1 Activation 232
A yeast-based repurposing approach revealed modulation of dNTP pool as a therapeutic target to treat mitochondrial DNA depletion syndromes 217
Decline of cardiomyocyte contractile performance and bioenergetic function in socially stressed male rats 200
DNA polymerase [gamma] and disease: what we have learned from yeast 198
Repeated witness social stress causes cardiomyocyte contractile impairment and intracellular Ca2+ derangement in female rats 197
Pathological alleles of MPV17 modeled in the yeast Saccharomyces cerevisiae orthologous gene SYM1 reveal their inability to take part in a high molecular weight complex 191
Sabotage at the powerhouse? Unraveling the Molecular Target of 2-Isopropylbenzaldehyde Thiosemicarbazone, a Specific Inhibitor of Aflatoxin Biosynthesis and Sclerotia Development in Aspergillus flavus, Using Yeast as a Model System 188
Yeast models of human MTO1 variants confirm two diagnoses of mitochondrial modopathy 184
Defective PITRM1 mitochondrial peptidase is associated with Aβ amyloidotic neurodegeneration 182
Pathogenic variants in glutamyl-tRNAGlnamidotransferase subunits cause a lethal mitochondrial cardiomyopathy disorder 180
Drug Drop Test: How to Quickly Identify Potential Therapeutic Compounds for Mitochondrial Diseases Using Yeast Saccharomyces cerevisiae 175
A single nucleotide polymorphism in the DNA polymerase gamma gene of Saccharomyces cerevisiae laboratory strains is responsible for increased mitochondrial DNA mutability 175
Defective mitochondrial rRNA methyltransferase MRM2 causes MELAS-like clinical syndrome 173
Elongator-dependent modification of cytoplasmic tRNALysUUU is required for mitochondrial function under stress conditions 171
A yeast-based repurposing approach for the treatment of mitochondrial DNA depletion syndromes led to the identification of molecules able to modulate the dNTP pool 171
A homozygous mutation in LYRM7/MZM1L associated with early onset encephalopathy, lactic acidosis and severe reduction of mitochondrial complex III activity. 167
Study of the effects of potentially beneficial molecules on the mitochondrial dNTP pool in a model of Hepatocerebral Mitochondrial DNA Depletion Syndrome caused by mutations in the MPV17 gene 166
The Power of Yeast in Modelling Human Nuclear Mutations Associated with Mitochondrial Diseases 164
Clinical Features, Molecular Heterogeneity, and Prognostic Implications in YARS2-Related Mitochondrial Myopathy 163
Yeast as a model system to shed light on the role of the human disease protein Mpv17 162
Yeast as a model of mitochondrial dysfunctions: neurodegenerative diseases and cancer. 161
Characterization of the BCS1L c.38A>G variant identified in a patient with Biörnstad syndrome 160
A Novel Homozygous YARS2 Mutation in Two Italian Siblings and a Review of Literature 160
Yeast as a model system for diseases associated with defective coenzyme a metabolism 159
The identification of beneficial molecules for mitochondrial diseases: Saccharomyces cerevisiae as powerful model 159
Saccharomyces cerevisiae as a tool for studying mutations in nuclear genes involved in diseases caused by mitochondrial DNA instability 156
Pathogenic variants in GCSH encoding the moonlighting H-protein cause combined Nonketotic Hyperglycinemia and Lipoate Deficiency 155
A yeast-based screening unravels potential therapeutic molecules for mitochondrial diseases associated with dominant ant1 mutations 151
Dominance of yeast aac2R96H and aac2R252G mutations, equivalent to pathological mutations in ant1, is due to gain of function 149
De Novo DNM1L Pathogenic Variant Associated with Lethal Encephalocardiomyopathy—Case Report and Literature Review 148
In-frame deletion in canine PITRM1 is associated with a severe early-onset epilepsy, mitochondrial dysfunction and neurodegeneration 148
Genetic and chemical rescue of the Saccharomyces cerevisiae phenotype induced by mitochondrial DNA polymerase mutations associated with progressive externalophthalmoplegia in humans 147
Yeast expression of mammalian Onzin and fungal FCR1 suggests ancestral functions of PLAC8 proteins in mitochondrial metabolism and DNA repair 146
Saccharomyces cerevisiae as a model for the identification of beneficial molecules for mitochondrial diseases. 146
The power of yeast in modeling human mutations leading to mitochondrial disease:the case of ANT1, YARS2, DNM1L and LYRM7. 144
Genetic, physiological and molecular characterization of MPV17/SYM1 mutations in S. cerevisiae 142
YEAST MODEL FOR NOVEL AARS2 MUTATIONS ASSOCIATED WITH PROGRESSIVE LEUKOENCEPHALOPATHY AND CEREBELLAR ATAXIA 141
Mitochondrial Aminoacyl-tRNA Synthetase: The Power Of Yeast In Modeling Human Pathological Mutations 141
Sideroblastic anemia with myopathy secondary to novel, pathogenic missense variants in the YARS2 gene 141
Uncovering a Novel Pathogenic Mechanism of BCS1L in Mitochondrial Disorders: Insights from Functional Studies on the c.38A>G Variant. 140
DEFECTIVE MITOCHONDRIAL rRNA METHYLTRANSFERASE (MRM2) CAUSES A MELAS-LIKE SYNDROME 140
Polymorphisms in DNA polymerase γ affect the mtDNA stability and the NRTI-induced mitochondrial toxicity in Saccharomyces cerevisiae 140
Childhood obsessive-compulsive disorder, epigenetics, and heterochrony: An evolutionary and developmental approach 139
Characterization of the Saccharomyces cerevisiae SYM1 gene, ortholog of the human desease gene MPV17 138
Modeling human Coenzyme A synthase mutation in yeast reveals altered mitochondrial function, lipid content and iron metabolism 136
De novo DNM1L pathogenic variant associated with lethal encephalocardiomyopathy and a literature review 135
A simple organism to address big questions: how Saccharomyces cerevisiae can support mitochondrial medicine 135
Saccharomyces cerevisiae as a system to discover beneficial molecules for mitochondrial diseases 134
SYM1, the yeast ortholog of the MPV17 human disease gene, is required for TCA function, mtDNA stability and mitochondrial morphology in stress conditions 132
Case Series and DARS2 Variant Analysis in Early Severe Forms With Unexpected Presentations 131
Transcriptomics on yeast models to deepen the knowledge of mitochondrial disease-associated pathways 130
Research of potentially therapeutic molecules for Hepatocerebral Mitochondrial DNA Depletion Syndrome caused by mutations in the MPV17 gene 130
Mitochondrial aminoacyl‐trna synthetase and disease: The yeast contribution for functional analysis of novel variants 129
SYM1, the yeast ortholog of the MPV17 human disease gene, is required for TCA function, mtDNA stability and mitochondrial morphology in stress conditions 127
Epigenetic analyses in forensic medicine: future and challenges 127
Modopathies Caused by Mutations in Genes Encoding for Mitochondrial RNA Modifying Enzymes: Molecular Mechanisms and Yeast Disease Models 127
Pathological Role of Mutations in Human MPV17: Saccharomyces cerevisiae as a Model System 126
Defective mitochondrial rRNA methyltransferase MRM2 causes MELAS-like clinical syndrome 126
The polymorphism Val158Met in the COMT gene: disrupted dopamine system in fibromyalgia patients? 125
Mutations in the mitochondrial tryptophanyl-tRNA synthetase cause growth retardation and progressive leukoencephalopathy 125
A potential link between inflammatory profiles, clinical pain, pain catastrophizing and long‐term outcomes after total knee arthroplasty surgery 123
MUTATIONS IN THE GENES QRSL1, GATB, AND GATC ENCODING THE SUBUNITS OF GLUTAMYL-TRNA(GLN) AMIDOTRANSFERASE CAUSE A MITOCHONDRIAL DISORDER WITH LETHAL INFANTILE CARDIOMYOPATHY 123
Sym1, the yeast ortholog of the MPV17 human disease protein, is a stress-induced bioenergetic and morphogenetic mitochondrial modulator 122
Repurposing Drugs for Mitochondrial Disorders: A Yeast-Based Approach for Complex III Assembly Defects 121
Saccharomyces cerevisiae, a model system to study the effect of mtDNA polymerase mutations associated with PEO in humans. 121
VARS2 and TARS2 Mutations in Patients with Mitochondrial Encephalomyopathies 121
TRMT5 Mutations Cause a Defect in Post-transcriptional Modification of Mitochondrial tRNA Associated with Multiple Respiratory-Chain Deficiencies 120
The power of yeast in modeling human mutations: mitochondrial aminoacyl tRNA synthetases and mitochondrial tRNA modifiers 120
Pain mechanistic networks: the development using supervised multivariate data analysis and implications for chronic pain 118
Functional analysis of missense DARS2 variants in siblings with leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation 116
The power of yeast in modeling human mutations leading to mitochondrial disease 116
An Unusual Case of SUCLA2-related Mitochondrial DNA Depletion Syndrome Who Presented with Hepatopathy Following Chemotherapy: Molecular Analysis and Functional Study 116
Sym1, the yeast ortholog of the MPV17 human disease protein, is a stress-induced bioenergetic and morphogenetic mitochondrial modulator 114
Mitmed: a multicenter consortium for the identification and characterization of nuclear genes responsisble for human mitochondrial disorders 114
MTO1 mutations are associated with hypertrophic cardiomyopathy and lactic acidosis and cause respiratory chain deficiency in humans and yeast 110
The yeast Saccharomyces cerevisiae as a model to deepen the knowledge about the mitochondrial metallopeptidase PITRM1 in health and disease 109
LYRM7 mutations cause a multifocal cavitating leukoencephalopathy with distinct MRI appearance. 109
Recurrent De Novo Dominant Mutations in SLC25A4 Cause Severe Early-Onset Mitochondrial Disease and Loss of Mitochondrial DNA Copy Number 109
Predicting the contribution of novel POLG mutations to human disease through analysis in yeast model 107
Epigenetic alterations in prescription opioid misuse: New strategies for precision pain management 107
Saccharomyces cerevisiae: a powerful organism to study mitochondrial diseases and support mitochondrial medicine 106
The Saccharomyces cerevisiae yeast as a model system to study the human mitochondrial DNA depletion syndromes (MDDS) 103
Yeast-based screening to discover therapies for Complex III assembly defects. 100
MITMED: A MULTICENTER CONSORTIUM FOR THE IDENTIFICATION AND CHARACTERIZATION OF NUCLEAR GENES RESPONSIBLE FOR HUMAN MITOCHONDRIAL DISORDERS 100
The Saccharomyces cerevisiae mitochondrial DNA polymerase and its contribution to the knowledge about human POLG-related disorders 99
Phenotypic, molecular, and functional characterization of COQ7-related primary CoQ10 deficiency: Hypomorphic variants and two distinct disease entities 98
Mitochondrial diseases and the role of the yeast models. 97
Mutations of the mitochondrial-tRNA modifier MTO1 cause hypertrophic cardiomyopathy and lactic acidosis. 95
Targeting defects in assembly of the mitochondrial respiratory chain complexes by exploiting yeast models 93
Identification of potential therapeutic compounds for mitochondrial disorders due to mutations in mitochondrial respiratory chain assembly factors by exploiting yeast models 91
Role of ROS in mtDNA instability in ANT1-associated adPEO 89
Yeast as a model system to propose therapies for Mitochondrial Complex III Deficiency 84
The first recessive pathological mutation in the adenine nucleotide translocator: yeast as a model system 84
Novel (ovario) leukodystrophy related to AARS2 mutations 80
Mutations of the mitochondrial-tRNA modifier MTO1 cause hypertrophic cardiomyopathy and lactic acidosis 75
Yeast model of mitochondrial involvement of Aβ amyloidotic neurodegeneration 73
MTO1 MUTATIONS CAUSE RESPIRATORY CHAIN DEFICIENCY IN HUMANS AND YEAST 67
From Genetics to Epigenetics: The Steps of a Path 40
Sex-dependent salivary microRNA expression profiles and psychophysiological responses to acute stress in healthy adults 39
SYM1, l’ortologo di lievito del gene umano MPV17, codifica per una proteina indotta da stress che modula lo stato bioenergetico e morfogenetico del mitocondrio 1
Totale 13.212
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.302
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.302
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202136 0 0 0 0 0 0 0 0 0 0 0 36
2021/2022403 22 21 1 27 14 27 35 36 14 33 28 145
2022/20231.457 138 150 101 95 132 155 28 78 502 6 51 21
2023/2024756 57 66 37 28 57 145 39 60 17 74 66 110
2024/20252.544 44 90 122 141 290 385 142 115 358 203 193 461
2025/20265.934 476 527 730 485 742 267 682 172 740 398 392 323
Totale 13.212